Evaluation of the Feasibility of Developing Personalized Breast Cancer Radiotherapy Assistive Device With 3D Printing
NCT04929197 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2022-11-08
Summary
Breast cancer is the most common malignancy among women worldwide. For early stage breast cancer, adjuvant radiotherapy is essential to minimize loco-regional disease recurrence. However, significant portions of the heart and the lungs are exposed to low dose radiation during radiotherapy, which result in stochastic side effects among breast cancer survivors. Inspired by 3D printing technology, we approached this issue with an in-house made PERSonalized BReAst holder system (PERSBRA). PERSBRA is composed of a 3D-printed plastic holder covering the whole breast and an air-filled interface. Its main function is to reproducibly adjust the breast position to decrease heart and lung radiation exposure in tangential fields. Here we propose to measure the performance of PERSBR in terms of radiation dosimetry in 50 patients receiving scheduled whole breast irradiation. For customized PERSBRA, body shape of the patient with or without a bustier corset will be captured with a handheld 3D scanner and input into a 3D printer for PERSBRA design and manufacturing. A participant will receive two more CT scans in addition to the simulation scan with PERSBRA in place before the first and the sixth fractions of irradiation. These images will be analyzed for dosimetric parameters in the presence/absence of PERSBRA as well as position reproducibility. The data will provide proof-of-principle evidence for the clinical utility of PERSBRA and will facilitate its further refinement.
Conditions
- Breast Neoplasms
- Breast Cancer
- Left Sided Breast Cancer
Interventions
- DEVICE
-
PERSBRA
After the patient is in the semi-prone position, the body shape and breast position images are obtained by the stereo scanning technology, and then using 3d printing technology to print PERSBRA. PERSBRA maintain a favorable new breast position in the supine position during routine radiotherapy, the cardiopulmonary dose during radiotherapy can be reduced by wearing PERSBRA.
Sponsors & Collaborators
-
Taipei Medical University Hospital
lead OTHER
Principal Investigators
-
Long-Sheng Lu, MD, Ph.D. · Taipei Medical University Hospital
-
Jeng-Feng Chiou, MD, Ph.D. · Taipei Medical University Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-21
- Primary Completion
- 2017-04-20
- Completion
- 2023-11-01
Countries
- Taiwan
Study Locations
More Related Trials
-
Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer
NCT00694577 ·Status: COMPLETED ·Phase: NA
-
Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer
NCT05976412 ·Status: RECRUITING ·Phase: NA
-
Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study
NCT07263451 ·Status: RECRUITING ·Phase: NA
-
Partial Breast Irradiation (PBI) for Selected Patients With Early Breast Cancer
NCT00325598 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Definitive Radiation Therapy for Inoperable Breast Cancer
NCT07122713 ·Status: RECRUITING ·Phase: NA
-
Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast Irradiation
NCT05772390 ·Status: RECRUITING ·Phase: PHASE2
-
Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer
NCT02076074 ·Status: COMPLETED ·Phase: NA
-
External-Beam Partial-Breast Irradiation for Early Breast Cancer 40 Gy QD Over 2 Weeks
NCT01581619 ·Status: COMPLETED ·Phase: NA
-
Partial Breast Irradiation for Low-risk Ductal Carcinoma In Situ After Breast-conserving Surgery
NCT02617082 ·Status: UNKNOWN
-
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients
NCT03270072 ·Status: ACTIVE_NOT_RECRUITING
-
Prophylactic Irradiation to the Contralateral Breast for BCAs Patients
NCT04960839 ·Status: RECRUITING ·Phase: NA
-
PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST
NCT06979921 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer
NCT03568981 ·Status: UNKNOWN
-
Quantitative Evaluation of the Breast's Morphological Variations During Radiotherapy: MorphoBreast3D
NCT03801850 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer
NCT00749437 ·Status: COMPLETED ·Phase: PHASE1
-
PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy
NCT02448576 ·Status: UNKNOWN ·Phase: NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
NCT05592938 ·Status: RECRUITING ·Phase: NA
-
Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast Cancer
NCT03242551 ·Status: UNKNOWN ·Phase: PHASE2
-
Single Dose Partial Breast Radiotherapy
NCT00944528 ·Status: COMPLETED ·Phase: PHASE1
-
Breast Radiotherapy Audio Visual Enhancement for Sparing the Heart
NCT02881203 ·Status: COMPLETED ·Phase: NA
-
The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure
NCT03375892 ·Status: COMPLETED ·Phase: NA
-
Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer
NCT02482376 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Deep Inspiration Breath-hold Radiotherapy for Left-sided Breast Cancer
NCT05200078 ·Status: UNKNOWN
-
Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients
NCT02982148 ·Status: UNKNOWN ·Phase: PHASE4
-
The Added Value of DBT Over Mammography in Local Tumor Staging in Patients With BIRADS 4 or 5 Lesions
NCT06854887 ·Status: NOT_YET_RECRUITING